YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Dec. 18, 2014 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq:RWLK) announced today the appointment of Kevin W. Hershberger, former controller and Chief Accounting Officer at NxStage Medical Inc., as Chief Financial Officer of the Company effective January 1, 2015. Ami Kraft has elected to transition from his current role as the Chief Financial Officer to a new role as General Manager of ReWalk’s Israel organization, and will assume his new role effective January 1, 2015.

“We are pleased to welcome to the company Kevin Hershberger, an experienced financial professional widely recognized in the medical device and manufacturing fields,” said Larry Jasinski, Chief Executive Officer. “His more than 25 years of hands-on experience and leadership responsibilities at organizations such as NxStage and Boston Scientific Corporation will be critical as we continue to execute ReWalk’s growth initiatives to bring our revolutionary technology to a broader group of individuals with spinal cord injuries.

“It goes without saying that many of our recent accomplishments are due to the tireless efforts of Ami Kraft, who has been a valued business advisor and highly effective CFO in establishing a solid footing for the company.  A very significant part of our success in the exoskeleton market is directly attributed to his personal commitment and leadership.  His new role as the General Manager for Israel is to provide support, advice, and leadership and we look forward to his ongoing contribution,” Jasinski added.

“I am excited to join ReWalk at such a momentous period in its growth trajectory,” said Kevin Hershberger. “I look forward to becoming part of ReWalk’s senior management team as we take on the challenges of expanding the company’s reach into additional geographies as well as facilitating further penetration in the exoskeleton marketplace.”

Kevin Hershberger most recently served as Vice President, Controller and Chief Accounting Officer at NxStage Medical Inc., a Nasdaq-listed manufacturer of innovative dialysis products. During his over six-year tenure, Mr. Hershberger led the financial operations, improved gross margins, participated in fund-raising activities, and established a joint venture manufacturing operation in Germany.  Prior to NxStage, Mr. Hershberger worked for nearly ten years in positions of increasing responsibility at the NYSE-listed Boston Scientific Corporation, a global developer, manufacturer and distributor of less invasive medical devices, ultimately serving as Controller/Director Finance—Urology & Gynecology.  Mr. Hershberger began his career as an accountant at the USG Corporation, a global manufacturer and distributor of building materials.  Mr. Hershberger is a graduate of West Virginia University with a Bachelors of Science degree in accounting, and a Company Commander in the U.S. Army Reserves.